{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:23:10Z","timestamp":1788304990858,"version":"build-2803163510"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2011,4,6]],"date-time":"2011-04-06T00:00:00Z","timestamp":1302048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Common variable immunodeficiency disorders (CVIDs) are the most frequent symptomatic primary immunodeficiencies in adults. They comprise a heterogeneous group of pathologies, with frequent non-infectious complications in addition to the bacterial infections that usually characterize their presentation. Complications include a high risk of malignancy, especially lymphoma and gastric cancer. Helicobacter pylori infection and pernicious anaemia are risk predictors for gastric cancer in the general population and probably in patients with CVIDs. Screening for gastric cancer in a high-risk population appears to improve survival. Given the increased risk of gastric cancer in patients with CVIDs and prompted by a case of advanced gastric malignancy in a patient with a CVID and concomitant pernicious anaemia, we performed a review of the literature for gastric cancer and conducted a cohort study of gastric pathology in 116 patients with CVIDs under long-term follow-up in Oxford. Regardless of the presence of pernicious anaemia or H. pylori infection, patients with CVIDs have a 10-fold increased risk of gastric cancer and are therefore a high-risk population. Although endoscopic screening of all patients with CVIDs could be considered, a more selective approach is appropriate and we propose a surveillance protocol that should reduce modifiable risk factors such as H. pylori, in order to improve the management of patients with CVIDs at risk of gastric malignancy.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2011.04384.x","type":"journal-article","created":{"date-parts":[[2011,4,7]],"date-time":"2011-04-07T02:05:12Z","timestamp":1302141912000},"page":"1-7","source":"Crossref","is-referenced-by-count":89,"title":["Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme"],"prefix":"10.1093","volume":"165","author":[{"given":"F","family":"Dhalla","sequence":"first","affiliation":[{"name":"Core Medical Trainee, Imperial NHS Trust, London Deanery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S P","family":"da Silva","sequence":"additional","affiliation":[{"name":"Immunoallergology Department, Santa Maria Hospital, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lucas","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Nuffield Department of Medicine, University of Oxford and Oxford Radcliffe Hospitals"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Travis","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Chapel","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Nuffield Department of Medicine, University of Oxford and Oxford Radcliffe Hospitals"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,4,6]]},"reference":[{"key":"2021122708474515300_b1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2249.2009.04013.x","article-title":"Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation","volume":"158","author":"Fevang","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2021122708474515300_b2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","article-title":"Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)","volume":"93","author":"Conley","year":"1999","journal-title":"Clin Immunol"},{"key":"2021122708474515300_b3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br J Haematol"},{"key":"2021122708474515300_b4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gut.45.1.77","article-title":"Gastric pathology in patients with common variable immunodeficiency","volume":"45","author":"Zullo","year":"1999","journal-title":"Gut"},{"key":"2021122708474515300_b5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"2021122708474515300_b6","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","article-title":"Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review","volume":"31","author":"Daniels","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2021122708474515300_b7","first-page":"e201","article-title":"Gastric adenocarcinoma occurring in a young patient with common variable immunodeficiency syndrome","volume":"50","author":"Yap","year":"2009","journal-title":"Singapore Med J"},{"key":"2021122708474515300_b8","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(85)92399-2","article-title":"Hypogammaglobulinaemia and gastric cancer","volume":"1","author":"Lamers","year":"1985","journal-title":"Lancet"},{"key":"2021122708474515300_b9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00005176-198805000-00025","article-title":"Multifocal adenocarcinoma of the stomach in a child with common variable immunodeficiency","volume":"7","author":"Conley","year":"1988","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021122708474515300_b10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","article-title":"Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study","volume":"130","author":"Mellemkjaer","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2021122708474515300_b11","first-page":"136","article-title":"Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency","volume":"64","author":"Desar","year":"2006","journal-title":"Neth J Med"},{"key":"2021122708474515300_b12","first-page":"ECR61","article-title":"Common variable immunodeficiency patient with large granular lymphocytosis developing extranodal diffuse large B-cell lymphoma: a case report","volume":"91","author":"Delia","year":"2006","journal-title":"Haematologica"},{"key":"2021122708474515300_b13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"2021122708474515300_b14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3748\/wjg.v12.i3.354","article-title":"Epidemiology of gastric cancer","volume":"12","author":"Crew","year":"2006","journal-title":"World J Gastroenterol"},{"key":"2021122708474515300_b15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0959-8049(01)00008-9","article-title":"The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses","volume":"37","author":"Berrino","year":"2001","journal-title":"Eur J Cancer"},{"key":"2021122708474515300_b16","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","article-title":"Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world","volume":"24","author":"Kamangar","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021122708474515300_b17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jjco\/hyn017","article-title":"The Japanese guidelines for gastric cancer screening","volume":"38","author":"Hamashima","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"2021122708474515300_b18","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/ijc.21664","article-title":"Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan","volume":"118","author":"Lee","year":"2006","journal-title":"Int J Cancer"},{"key":"2021122708474515300_b19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ypmed.2006.07.016","article-title":"Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based cohort study","volume":"44","author":"Miyamoto","year":"2007","journal-title":"Prev Med"},{"key":"2021122708474515300_b20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1572-0241.2008.01819.x","article-title":"Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer","volume":"103","author":"Talley","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"2021122708474515300_b21","first-page":"281","article-title":"[Principles and practice of mass screening for disease]","volume":"65","author":"Wilson","year":"1968","journal-title":"Bol Oficina Sanit Panam"},{"key":"2021122708474515300_b22","first-page":"587","article-title":"Working group report on schistosomes, liver flukes and Helicobacter pylori","volume":"60","author":"Moller","year":"1995","journal-title":"Int J Cancer"},{"key":"2021122708474515300_b23","first-page":"1","article-title":"Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7\u201314 June 1994","volume":"61","author":"Working Group","year":"1994","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"2021122708474515300_b24","first-page":"4737","article-title":"Gastric precancerous process in a high risk population: cohort follow-up","volume":"50","author":"Correa","year":"1990","journal-title":"Cancer Res"},{"issue":"1","key":"2021122708474515300_b25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2036.1996.22164011.x","article-title":"The relationships between chronic gastritis and gastric acid secretion","volume":"10","author":"Sipponen","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"2021122708474515300_b26","first-page":"6735","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process \u2013 First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention","volume":"52","author":"Correa","year":"1992","journal-title":"Cancer Res"},{"key":"2021122708474515300_b27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0140-6736(94)91034-0","article-title":"H. pylori and gastric cancer","volume":"343","author":"Forman","year":"1994","journal-title":"Lancet"},{"key":"2021122708474515300_b28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.1365-2036.1999.00546.x","article-title":"Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies","volume":"13","author":"Danesh","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"2021122708474515300_b29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.49.3.347","article-title":"Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts","volume":"49","author":"Helicobacter and Cancer Collaborative Group","year":"2001","journal-title":"Gut"},{"key":"2021122708474515300_b30","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(76)90962-4","article-title":"Gastric-juice nitrite. A risk factor for cancer in the hypochlorhydric stomach?","volume":"2","author":"Ruddell","year":"1976","journal-title":"Lancet"},{"key":"2021122708474515300_b31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(78)90550-0","article-title":"Pathogenesis of gastric cancer in pernicious anaemia","volume":"1","author":"Ruddell","year":"1978","journal-title":"Lancet"},{"key":"2021122708474515300_b32","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1007\/BF02214873","article-title":"Effects of acid suppression on microbial flora of upper gut","volume":"40","author":"Yeomans","year":"1995","journal-title":"Dig Dis Sci"},{"key":"2021122708474515300_b33","volume-title":"Precancerous lesions of the gastrointestinal tract","author":"Varis","year":"1983"},{"key":"2021122708474515300_b34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/1097-0142(19930201)71:3<745::AID-CNCR2820710316>3.0.CO;2-1","article-title":"Pernicious anemia and subsequent cancer. A population-based cohort study","volume":"71","author":"Hsing","year":"1993","journal-title":"Cancer"},{"key":"2021122708474515300_b35","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/gut.52.7.938","article-title":"Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia","volume":"52","author":"Ye","year":"2003","journal-title":"Gut"},{"key":"2021122708474515300_b36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(85)91037-2","article-title":"Prospective study of cancer in patients with hypogammaglobulinaemia","volume":"1","author":"Kinlen","year":"1985","journal-title":"Lancet"},{"key":"2021122708474515300_b37","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/jcp.38.8.946","article-title":"Microbial and metabolic profile of achlorhydric stomach: comparison of pernicious anaemia and hypogammaglobulinaemia","volume":"38","author":"Borriello","year":"1985","journal-title":"J Clin Pathol"},{"key":"2021122708474515300_b38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J Clin Immunol"},{"key":"2021122708474515300_b39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"2021122708474515300_b40","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1182\/blood-2010-03-272351","article-title":"Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?","volume":"116","author":"Vajdic","year":"2010","journal-title":"Blood"},{"key":"2021122708474515300_b41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2249.2009.03909.x","article-title":"Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia","volume":"156","author":"Desar","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2021122708474515300_b42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0002-9343(69)90218-6","article-title":"The syndrome of immunoglobulin deficiency and pernicious anemia. A study of ten cases","volume":"47","author":"Twomey","year":"1969","journal-title":"Am J Med"},{"key":"2021122708474515300_b43","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/MEG.0b013e3283013d58","article-title":"Long-term follow-up study of gastric intraepithelial neoplasias: progression from low-grade dysplasia to invasive carcinoma","volume":"20","author":"Park","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2021122708474515300_b44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1523-5378.2008.00589.x","article-title":"We would welcome guidelines for surveillance of patients with gastric atrophic chronic and intestinal metaplasia!","volume":"13","author":"Dinis-Ribeiro","year":"2008","journal-title":"Helicobacter"},{"key":"2021122708474515300_b45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2249.2009.03913.x","article-title":"Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency","volume":"156","author":"Horn","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2021122708474515300_b46","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.4049\/jimmunol.178.6.3932","article-title":"Unravelling the complexity of T cell abnormalities in common variable immunodeficiency","volume":"178","author":"Giovannetti","year":"2007","journal-title":"J Immunol"},{"key":"2021122708474515300_b47","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","article-title":"Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years","volume":"125","author":"Lucas","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"2021122708474515300_b48","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1440-1746.2008.05314.x","article-title":"Asia-Pacific consensus guidelines on gastric cancer prevention","volume":"23","author":"Fock","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"2021122708474515300_b49","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/gut.2005.072009","article-title":"Long term follow up of patients treated for Helicobacter pylori infection","volume":"54","author":"Mera","year":"2005","journal-title":"Gut"},{"key":"2021122708474515300_b50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2007.00475.x","article-title":"The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection","volume":"12","author":"de Vries","year":"2007","journal-title":"Helicobacter"},{"key":"2021122708474515300_b51","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1086\/598198","article-title":"Accuracy of diagnostic tests for Helicobacter pylori: a reappraisal","volume":"48","author":"Calvet","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021122708474515300_b52","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00042737-200606000-00004","article-title":"Comparison of three stool antigen assays with the 13C\u2013 urea breath test for the primary diagnosis of Helicobacter pylori infection and monitoring treatment outcome","volume":"18","author":"Hooton","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2021122708474515300_b53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1083-4389.2004.00235.x","article-title":"Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review","volume":"9","author":"Gisbert","year":"2004","journal-title":"Helicobacter"},{"key":"2021122708474515300_b54","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3748\/wjg.14.1477","article-title":"H. pylori recurrence after successful eradication","volume":"14","author":"Niv","year":"2008","journal-title":"World J Gastroenterol"},{"key":"2021122708474515300_b55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/jcp.2003.11270","article-title":"A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia","volume":"57","author":"Dinis-Ribeiro","year":"2004","journal-title":"J Clin Pathol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2011.04384.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/165\/1\/1\/41908430\/j.1365-2249.2011.04384.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/165\/1\/1\/41908430\/j.1365-2249.2011.04384.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T11:23:19Z","timestamp":1641036199000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/165\/1\/1\/6422868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,6]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,4,6]]},"published-print":{"date-parts":[[2011,6,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04384.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,7]]},"published":{"date-parts":[[2011,4,6]]}}}